Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by "Софарма" АдfiledCritical"Софарма" Ад
Priority to BG108898UpriorityCriticalpatent/BG852Y1/en
Publication of BG108898UpublicationCriticalpatent/BG108898U/en
Publication of BG852Y1publicationCriticalpatent/BG852Y1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
The medicamentous form is administered orally and comprises 2-oxopyrrolidine-1-acetamide known as pyracetam, in high concentration. It is stable and has high degree of releasing the medicamentous substance. The composition allows the inclusion of active substance of different particle size distribution, the tablet core produced is stable to moisture and allows film-coating on aqueous basis.
BG108898U2004-10-072004-10-07Medicamentous form of pyracetam
BG852Y1
(en)
Granular pharmaceutical formulation with time-limited release for oral administration, and intraoral rapid disintegrating tablet containing the preparation
Compressed solid dosage form manufacturing process well-suited for use with drugs of low aqueous solubility and compressed solid dosage forms made thereby